Dr. Ramkishan Nag is a distinguished Surgical Oncologist renowned for his expertise in advanced laparoscopic and robotic cancer surgeries. With a strong commitment to delivering personalized and evidence-based cancer care, he combines surgical excellence with a compassionate, patient-first approach to help patients navigate their cancer journey with confidence and hope.
Trained at the prestigious Tata Memorial Hospital, Mumbai, Dr. Nag has extensive experience in the diagnosis and surgical management of a wide range of cancers, including gastrointestinal, colorectal, liver, pancreatic, peritoneal surface, breast, and gynecologic malignancies. His proficiency in minimally invasive surgical techniques allows patients to benefit from smaller incisions, reduced postoperative pain, shorter hospital stays, and faster recovery.
Over the course of his career, Dr. Nag has successfully performed thousands of complex cancer surgeries and remains at the forefront of modern oncological advancements. He is highly skilled in specialized treatments such as HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy), offering innovative treatment options for patients with advanced abdominal cancers.
Known for his precision, dedication, and ethical medical practice, Dr. Ramkishan Nag strives to provide comprehensive cancer care tailored to each patient’s unique needs. His goal is not only to achieve the best oncological outcomes but also to preserve quality of life, promote faster recovery, and support patients and their families throughout every stage of treatment.
Through his expertise, empathy, and unwavering commitment to excellence, Dr. Nag continues to make a meaningful difference in the lives of cancer patients by delivering world-class surgical oncology care with trust, compassion, and innovation.
HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is a specialized treatment used for selected patients with peritoneal surface malignancies. According to Dr Ramkishan Nag, Surgical Oncologist in Mumbai, HIPEC is performed after complete cytoreductive surgery to eliminate microscopic cancer cells and is suitable only for carefully selected patients.
Peritoneal cancer is not universally curable, but long-term disease control is possible in selected patients. Dr Ramkishan Nag explains that outcomes depend on tumor biology, disease burden, and completeness of surgical cytoreduction.
Patients with very extensive disease, poor performance status, aggressive tumor biology, or extra-abdominal metastases are generally not candidates. Dr Ramkishan Nag emphasizes that inappropriate HIPEC can cause harm without benefit.
Cancers such as ovarian cancer, appendiceal tumors, colorectal cancer, and peritoneal mesothelioma may benefit. According to Dr Ramkishan Nag, benefit depends on PCI score and ability to achieve complete cytoreduction.
Recovery typically takes 6–12 weeks. Dr Ramkishan Nag notes that patients require ICU monitoring initially, followed by gradual mobilization and nutritional rehabilitation.
When performed in experienced centers with proper patient selection, HIPEC can be safe. Dr Ramkishan Nag stresses that complication rates rise significantly when selection criteria are ignored.
Surgery is avoided when disease is diffuse, unresectable, or associated with aggressive biology. According to Dr Ramkishan Nag, systemic therapy is preferred in such cases.
It is a surgical approach that removes liver tumors while preserving maximum healthy liver tissue. Dr Ramkishan Nag advocates this technique to reduce liver failure and enable future treatments if needed.
In selected patients, long-term survival and cure are possible. Dr Ramkishan Nag explains that cure depends on tumor biology, number of lesions, and response to chemotherapy.
Surgery is avoided in uncontrolled primary disease, poor liver reserve, or rapidly progressive systemic disease. Dr Ramkishan Nag highlights the importance of MDT decisions.
Yes, when used appropriately. According to Dr Ramkishan Nag, robotic surgery offers precision and faster recovery without compromising oncological principles.
Robotic surgery improves recovery and precision, but survival depends on tumor biology. Dr Ramkishan Nag emphasizes that technology complements — not replaces — sound oncology.
Open surgery is preferred in very advanced tumors or when tactile feedback and rapid control are required. Dr Ramkishan Nag chooses approach based on oncologic safety, not convenience.
Decisions are made jointly by surgeons, medical oncologists, radiologists, and pathologists. Dr Ramkishan Nag stresses multidisciplinary planning for optimal outcomes.
Second opinions help confirm indication and avoid overtreatment. According to Dr Ramkishan Nag, major cancer surgery should never be rushed.
Neoadjuvant chemotherapy helps downstage disease and assess biology. Dr Ramkishan Nag uses response to guide surgical decisions.
With proper technique, the risk is minimal. Dr Ramkishan Nag explains that modern oncologic surgery follows strict tumor-handling principles.
Risks include infection, bleeding, organ dysfunction, and prolonged recovery. Dr Ramkishan Nag balances risk against realistic benefit.
CC score measures completeness of tumor removal. According to Dr Ramkishan Nag, CC-0 or CC-1 resections offer the best outcomes.
PCI (Peritoneal Cancer Index) quantifies disease burden. Dr Ramkishan Nag uses it to decide feasibility of CRS + HIPEC.
CRS + HIPEC can take 6–10 hours. Dr Ramkishan Nag explains that duration depends on disease extent and complexity.
Pain is managed with modern protocols. Dr Ramkishan Nag emphasizes early mobilization and pain control.
Most patients resume normal activities in 2–3 months. According to Dr Ramkishan Nag, recovery varies individually.
Yes, in selected recurrent or advanced cases. Dr Ramkishan Nag stresses correct timing and patient selection.
Patients should ask about benefit, alternatives, risks, recovery, and outcomes. Dr Ramkishan Nag believes informed patients make better decisions.
Looking for expert cancer care and surgical consultation? Book an Appointment